ascopubs.org

Risk of Positive Margins and Biochemical Recurrence in Relation to Nerve-Sparing Radical ...

Phase II Study of Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors (E9897): A Trial of the Eastern Cooperative Oncology Group PURPOSE: To assess the effect of nerve-sparing (NS) radical ...